Health Care & Life Sciences » Pharmaceuticals | Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
137.27 M
Public Float
105.61 M
Ionis Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.48
Market Cap
$9.06 B
Shares Outstanding
140.32 M
Public Float
124.9 M
Ionis Pharmaceuticals Inc.
Stock Exchange SIX Swiss Exchange
EPS
-
Market Cap
-
Shares Outstanding
137.27 M
Public Float
105.61 M

Profile

Address
2855 Gazelle Court
Carlsbad California 92010
United States
Employees -
Website http://www.ionispharm.com
Updated 07/08/2019
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs.

Financials

View All

Stanley T. Crooke
Chairman, President & Chief Executive Officer
B. Lynne Parshall
Director